openPR Logo
Press release

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG

10-25-2024 08:18 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: ABNewswire

Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS,

These five companies, all trading under $0.10, present speculative opportunities for investors looking to find undervalued businesses with tremendous upside potential. As October unfolds, these stocks may witness significant market movements, offering attractive entry points for those willing to take calculated risks.

CNS Pharmaceuticals Inc. (NASDAQ: CNSP), focused on developing novel treatments for central nervous system cancers, has captured investor interest with a promising drug pipeline. CNSP's stock, trading under $0.10, offers a speculative bet on future oncology breakthroughs, fueled by recent progress in clinical trials.

Qualigen Therapeutics Inc. (NASDAQ: QLGN) continues advancing life-enhancing therapies for cancer and infectious diseases. With its current stock price dipping below $0.10, QLGN represents a compelling buy for those optimistic about the company's clinical advancements and strategic partnerships.

Akoustis Technologies, Inc. (NASDAQ: AKTS), a leader in RF filter technology, faces market pressure as shares fall below $0.10. However, its core technology and next-generation wireless applications make AKTS an attractive option for tech-focused investors seeking value.

1606 Corp (OTC: CBDW) is making waves by acquiring a strategic stake in Adnexus Biotechnologies to bolster its capabilities in AI-driven drug discovery and infectious disease research, marking a significant move in healthcare and biotechnology.

RJD Green Inc. (OTC: RJDG), with a diversified business model in environmental services, healthcare, and construction, has seen its stock fall below $0.10. For investors seeking exposure to multiple industries, RJDG offers strong speculative potential at this price point.

As these stocks continue to trade under ten cents, they provide unique opportunities for investors ready to embrace risk for the chance of significant returns. With companies like CNS Pharmaceuticals (NASDAQ: CNSP), Qualigen Therapeutics (NASDAQ: QLGN), Akoustis Technologies (NASDAQ: AKTS), 1606 Corp (OTC: CBDW) and RJD Green (OTC: RJDG), showing promise in their respective fields, October 2024 could bring high stakes and rewarding outcomes for those keeping a close watch on these under-the-radar stocks.

Disclaimers: The Private Securities Litigation Reform Act of 1995 provides investors with a safe harbor with regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, assumptions, objectives, goals, and assumptions about future events or performance are not statements of historical fact and may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties that could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements, indicating certain actions & quotes; may, could or might occur Understand there is no guarantee past performance is indicative of future results. Investing in micro-cap or growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investor's investment may be lost or due to the speculative nature of the companies profiled. TheStreetReports (TSR) is responsible for the production and distribution of this content."TSR" is not operated by a licensed broker, a dealer, or a registered investment advisor. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. "TSR" authors, contributors, or its agents, may be compensated for preparing research, video graphics, podcasts and editorial content. "TSR" has not been compensated to produce content related to "Any Companies" appearing herein. As part of that content, readers, subscribers, and everyone viewing this content are expected to read the full disclaimer in our website.

Media Contact
Company Name: The Street Reports
Contact Person: Editor
Email:Send Email [https://www.abnewswire.com/email_contact_us.php?pr=stocks-under-ten-cents-to-watch-in-october-2024-cnsp-qlgn-akts-cbdw-rjdg]
Country: United States
Website: http://www.thestreetreports.com



This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Stocks Under Ten Cents to Watch in October 2024 CNSP, QLGN, AKTS, CBDW, RJDG here

News-ID: 3710475 • Views:

More Releases from ABNewswire

Abby Yoga Studio Expands with Private Yoga Therapy Sessions
Abby Yoga Studio Expands with Private Yoga Therapy Sessions
Certified Yoga Therapy instructor offers tailored Iyengar-based practices for health needs. Image: https://www.abnewswire.com/upload/2025/10/f6b927744919d106273aa8b6f23c144c.jpg Abbotsford, BC - Abby Yoga Studio has introduced private yoga therapy sessions, focusing on personalized assessments and adapted practices for individuals or small groups. Applying Iyengar yoga therapy principles, these one-on-one or limited-group classes address physical and emotional challenges, integrating mind-body healing to restore natural function. Led by Eileen Millar, a Level Three certified Iyengar teacher and C-IAYT yoga therapist,
Zil Money Launches ZilRemit as Dedicated International Payment Platform
Zil Money Launches ZilRemit as Dedicated International Payment Platform
New Standalone Platform Offers Seamless, Low-Cost Global Payments for Businesses and Personal Use, with Easy App Access and Faster Transaction Processing. Image: https://www.abnewswire.com/upload/2025/10/491fa4dc34bd8bd434ab18aeac2e7e4f.jpg TYLER, TX, USA - Oct 09, 2025 - Zil Money, a leading B2B payment platform, today announced the launch of ZilRemit, a dedicated platform for its international payment services. The new platform provides a focused identity for the company's high-speed, low-cost global payment solution, enabling businesses and individuals to
Shashishekhar Ramagundam: Driving Innovation in AI and Content Discovery at ORCID
Shashishekhar Ramagundam: Driving Innovation in AI and Content Discovery at ORCI …
Image: https://www.abnewswire.com/upload/2025/10/be0969e168c2d58f071b39a1d5c5c91e.jpg Shashishekhar Ramagundam [https://www.linkedin.com/in/shashishekhar-ramagundam-051a1233b] is a computer scientist and senior IEEE member whose career has centered on advancing Machine Learning, artificial intelligence (AI) and scalable content delivery. His research and professional responsibilities directly address critical challenges in streaming media, recommendations, and enterprise-level data security, impacting both academic progress and industry practices. Educational and Professional Background Ramagundam earned a master's degree in computer science from Troy University, Alabama, in 2014, with academic strengths
Conceivable's Proven Fertility Platform Delivers 260% Increase in Natural Conception Through Integrated Virtual Care Model
Conceivable's Proven Fertility Platform Delivers 260% Increase in Natural Concep …
Conceivable, the comprehensive women's health technology platform, has demonstrated remarkable clinical results with its virtual care approach, increasing the likelihood of natural conception by 260% for couples struggling with infertility. The company's integrated model combines fertility coaching, nutrition, culinary support, mental health services, and data science to address the root causes of infertility through personalized, evidence-based interventions. Conceivable is revolutionizing fertility care with a virtual platform that has achieved what many

All 5 Releases


More Releases for CNS

CNS promotes craftsmanship of towel production in China
[https://youtu.be/oP-N73N0ey0] China News Service (CNS) issued a press release and a promo video here on Wednesday to promote the unique craftsmanship of towel production in Gaoyang [https://youtu.be/oP-N73N0ey0] County of Chinese northern Hebei Province. According to the CNS press release, Gaoyang is the largest hub of towel production in China, where one out of every three towels in the nation originates. More than 4200 textile enterprises are competing to flourish in this region,
Gene Therapy in CNS Disorder Market - Unlocking the Potential of Gene Therapy: T …
Newark, New Castle, USA: The "Gene Therapy in CNS Disorder Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors. Gene Therapy in CNS Disorder Market: https://www.growthplusreports.com/report/gene-therapy-in-cns-disorder-market/8886 This latest report
Central Nervous System (CNS) Therapeutic Market Central Nervous System (CNS) The …
MARKET INTRODUCTION The central nervous system (CNS) is the control panel of the body, which is responsible for cognition, movement, senses and emotions. Central nervous system diseases, is a group of neurological disorders that affect the structure or function of the brain or spinal cord, which collectively form the central nervous system (CNS). The CNS diseases include neurodegenerative diseases, neurodevelopmental diseases and traumatic injuries. Drugs such as analgesics, anesthetics, nervous system
Neuro Critical Care Market Insights in terms of volume and value 2018 to 2028(Mo …
Neuro critical care is an emerging field that combines the specialties that link neurology, neurosurgery, and critical care. Just as the field has evolved from primary focus on post-operative care to elective neurosurgical patients, the focus towards the resuscitation of neurological emergency cases such as traumatic brain injury or subarachnoid hemorrhage, which remain a clinical challenge. The neuro critical care market is strongly driven by the increasing focus, awareness, and
US CNS Disorders Drug Pipeline Insight 2014
The Central Nervous System (CNS) disorders market in US is one of the largest segments of pharmaceuticals industry. In US, the numbers of CNS disorders have increased at an alarming rate, while the available therapies were unable to meet the market requirements. There has been steady to rapid growth in the market for CNS disorder, especially over the past two decades. The market for CNS therapies is one of the
CNS Therapeutics Market Research Report 2016
“Global CNS Therapeutics Market Research Report 2016” Order This Report by calling BigMarketResearch.com at +1-971-202-1575 Notes: Production, means the output of CNS Therapeutics Revenue, means the sales value of CNS Therapeutics This report studies CNS Therapeutics in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering Pfizer, Inc. (USA) Johnson & Johnson (USA) Bristol-Myers Squibb